RxSight, Inc.

Healthcare

NASDAQ:RXST · NASDAQ Global Market

Market Cap $195.81M Beta 1.13 P/E (TTM) -4.1

$4.73 +0.98%

+$0.05 today

52W Low $4.48High $14.29

Vol 0.94M · Avg 0.80M

EPS (TTM) -$1.13Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-65.07%

Period High

$13.70

Period Low

$4.59

Latest

$4.73

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Butterfly Network, Inc.

NYSE:BFLY

$2.18B

Surmodics, Inc.

SRDX

$614.51M

Tactile Systems Technology, Inc.

NASDAQ:TCMD

$598.58M

Cerus Corporation

NASDAQ:CERS

$537.99M

NeuroPace, Inc.

NASDAQ:NPCE

$523.81M

OrthoPediatrics Corp.

NASDAQ:KIDS

$474.27M

Delcath Systems, Inc.

NASDAQ:DCTH

$405.63M

Semler Scientific, Inc.

SMLR

$310.75M

DiaMedica Therapeutics Inc.

NASDAQ:DMAC

$307.13M

Treace Medical Concepts, Inc.

NASDAQ:TMCI

$267.60M

What is the latest RXST filing?

The latest filing shown is 8-K dated Jun 16, 2026.

How many recent filings does RXST have?

Intrinsic Alpha currently shows 20 recent filings for RXST.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.